Yelena Y. Janjigian, MD

Dr Yelena Janjigian | Image Credit: Memorial Sloan Kettering Cancer Center

Yelena Y. Janjigian, MD, is chief of gastrointestinal oncology at Memorial Sloan Kettering Cancer Center.

Articles by Yelena Y. Janjigian, MD

Drs Yelena Janjigian and Zev Wainberg | Background image credit: ipopba - stock.adobe.com

Experts Say FDA Approval of Perioperative Durvalumab Plus FLOT Sets New Standard of Care for Early-Stage Gastric, GEJ Cancers

ByBrooke McCormick,Yelena Y. Janjigian, MD,Zev A. Wainberg, MD

December 3rd 2025

As the first immunotherapy option in this setting, the approval sets a new standard for resectable early-stage gastric and gastroesophageal junction (GEJ) cancers.

Yelena Y. Janjigian, MD

Articles by Yelena Y. Janjigian, MD

Experts Say FDA Approval of Perioperative Durvalumab Plus FLOT Sets New Standard of Care for Early-Stage Gastric, GEJ Cancers

Latest Updated Articles

Trending on AJMC

WHO Publishes GLP-1 Guidelines for Obesity Treatment

It’s Time to Reimagine Reimbursement for CAR T-Cell Therapy

What ACA Subsidy Expiration Means for Coverage Costs, Employer Strategy, and ICHRAs: Q&A With Ben Light

Frameworks for Advancing Health Equity: Dental Health Care Access

Integrated Care for Chronic Conditions: A Randomized Care Management Trial